Ropeginterferon Alfa-2b
Ropeginterferon Alfa-2b for MDS/MPN Overlap Syndromes, Including CMML and MDS/MPN-RS-T
More Information
- Trial Status
- Not yet accepting
- Trial Phase
- Phase 2
- Enrollment
- 35 patients (estimated)
- Tags
- Interferon Alfa-2b
- Trial Type
- Treatment
- Last Update
- SparkCures ID
- 2239
- NCT Identifier
- NCT07468916
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.